We are live on ! Find out more
Mirae Asset Global Investments

Mirae Asset Global Investments Portfolio holdings

AUM $67.7B
1-Year Est. Return 57.61%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$24.6B
AUM Growth
+$2.03B
Cap. Flow
+$1.28B
Cap. Flow %
5.2%
Top 10 Hldgs %
38.38%
Holding
1,702
New
151
Increased
731
Reduced
674
Closed
110

Sector Composition

Rank Sector Weight
1 Technology 33.15%
2 Consumer Discretionary 10.25%
3 Communication Services 8.94%
4 Healthcare 6.61%
5 Financials 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRNA
1126
DELISTED
Verona Pharma
VRNA
$114K ﹤0.01%
2,465
-145
-6% -$5.44K
RYTM icon
1127
Rhythm Pharmaceuticals
RYTM
$7.99B
$114K ﹤0.01%
2,048
-163
-7% -$9K
CRSP icon
1128
CRISPR Therapeutics
CRSP
$5.22B
$114K ﹤0.01%
2,844
-236
-8% -$11.1K
ALVO icon
1129
Alvotech
ALVO
$1.38B
$113K ﹤0.01%
+8,891
New +$109K
SBRA icon
1130
Sabra Healthcare REIT
SBRA
$5.15B
$111K ﹤0.01%
6,537
-2,448
-27% -$44.7K
NVCR icon
1131
NovoCure
NVCR
$2.02B
$111K ﹤0.01%
3,606
-308
-8% -$6.52K
THC icon
1132
Tenet Healthcare
THC
$21.5B
$110K ﹤0.01%
858
-517
-38% -$76.9K
GSL icon
1133
Global Ship Lease
GSL
$1.49B
$108K ﹤0.01%
4,987
-3,392
-40% -$79.2K
BRFS
1134
DELISTED
BRF SA
BRFS
$108K ﹤0.01%
26,351
+2,464
+10% +$10.7K
YEXT icon
1135
Yext
YEXT
$613M
$106K ﹤0.01%
16,763
-14,231
-46% -$103K
GAP
1136
The Gap Inc
GAP
$7.34B
$106K ﹤0.01%
4,350
-553
-11% -$12.6K
DESP
1137
DELISTED
Despegar.com
DESP
$104K ﹤0.01%
+5,400
New +$85K
NTNX icon
1138
Nutanix
NTNX
$18.4B
$104K ﹤0.01%
1,679
+711
+73% +$46.5K
SKT icon
1139
Tanger
SKT
$4.42B
$104K ﹤0.01%
3,052
-1,192
-28% -$41.5K
VCYT icon
1140
Veracyte
VCYT
$3.42B
$104K ﹤0.01%
2,583
-195
-7% -$7.38K
TEVA icon
1141
Teva Pharmaceuticals
TEVA
$42.6B
$102K ﹤0.01%
4,552
MAGN
1142
Magnera Corp
MAGN
$433M
$101K ﹤0.01%
+5,660
New +$116K
KTOS icon
1143
Kratos Defense & Security Solutions
KTOS
$11.8B
$100K ﹤0.01%
+3,785
New +$97K
BCH icon
1144
Banco de Chile
BCH
$20.5B
$100K ﹤0.01%
4,416
+1,291
+41% +$30.4K
GPCR icon
1145
Structure Therapeutics
GPCR
$3.89B
$99.7K ﹤0.01%
3,566
-218
-6% -$7.74K
AFRM icon
1146
Affirm
AFRM
$26.2B
$99.3K ﹤0.01%
1,589
+496
+45% +$27.6K
CII icon
1147
BlackRock Enhanced Captial and Income Fund
CII
$1.02B
$99K ﹤0.01%
4,914
-1,110
-18% -$22.1K
DNLI icon
1148
Denali Therapeutics
DNLI
$3.97B
$98.8K ﹤0.01%
4,796
-382
-7% -$9.78K
XENE icon
1149
Xenon Pharmaceuticals
XENE
$6.21B
$98.7K ﹤0.01%
2,541
-199
-7% -$8.23K
CDP icon
1150
COPT Defense Properties
CDP
$4.23B
$97.6K ﹤0.01%
3,144
-1,228
-28% -$39K

Similar funds

Mirae Asset Global Investments's Q4 2024 Portfolio in Review

As of Q4 2024, Mirae Asset Global Investments held 1,702 positions worth $24.6B, up 9% from $22.6B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Mirae Asset Global Investments deployed $1.28B of net new capital in Q4 2024, opening 151 new positions and adding to 731 existing holdings. Its largest new stake was Strategy Inc: 36,162 shares worth $11.8M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $81.5M trimmed.

  • Mirae Asset Global Investments's largest Q4 2024 buy was Strategy Inc: 36,162 shares worth $11.8M.
  • Mirae Asset Global Investments added most to Vanguard S&P 500 ETF in Q4 2024, an estimated $167M increase.
  • Mirae Asset Global Investments's biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $81.5M.
  • Mirae Asset Global Investments fully exited VanEck Pharmaceutical ETF in Q4 2024, selling an estimated $23.6M.
  • Mirae Asset Global Investments's ten largest holdings make up 38% of its $24.6B portfolio in Q4 2024.
  • Mirae Asset Global Investments opened 151 new positions and closed 110 in Q4 2024.
  • Mirae Asset Global Investments's portfolio value rose 9% quarter-over-quarter to $24.6B.

Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.